Program details:
This program will cover issues involved with representing US companies in their dealings with China.
The topics will include options for setting up operations in China, unique transactional issues, intellectual property, antitrust issues, and corporate/cultural considerations in doing business in and with China.
Panelists will also discuss the unique issues involved in representing Chinese companies in the United States.
People
Related Insights
July 16, 2025
Health Care Law Today Podcast
Episode 36: Let’s Talk Compliance: The Risks and Pitfalls of Health Care Supply Chain Compliance
In this episode, Monica Chmielewski, vice chair of Foley’s Health Care Practice Group and Shannon Sumner, Chief Compliance Officer and Nashville’s Office Managing Principal of PYA explore how supply chain compliance is affecting the health care industry and share the risks and penalties associated with not being in compliance.
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…